Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 907545, 7 pages
http://dx.doi.org/10.1155/2014/907545
Review Article

Novel Molecular Biomarkers at the Blood-Brain Barrier in ALS

Center for Laser Microscopy, Institute for Physiology and Biochemistry, Faculty of Biology, University of Belgrade, Studentski Trg 16, POB 52, 11000 Belgrade, Serbia

Received 14 February 2014; Revised 4 April 2014; Accepted 20 April 2014; Published 11 May 2014

Academic Editor: Raquel Manzano

Copyright © 2014 Danijela Bataveljic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. G. Miller, J. D. Mitchell, and D. H. Moore, “Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND),” Cochrane Database of Systematic Reviews, no. 3, Article ID CD001447, 2012. View at Google Scholar
  2. M. E. Gurney, H. Pu, A. Y. Chiu et al., “Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation,” Science, vol. 264, no. 5166, pp. 1772–1775, 1994. View at Google Scholar · View at Scopus
  3. D. S. Howland, J. Liu, Y. She et al., “Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS),” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 3, pp. 1604–1609, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. T. J. Kwiatkowski Jr., D. A. Bosco, A. L. LeClerc et al., “Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis,” Science, vol. 323, no. 5918, pp. 1205–1208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Sreedharan, I. P. Blair, V. B. Tripathi et al., “TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis,” Science, vol. 319, no. 5870, pp. 1668–1672, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Grosskreutz, L. van den Bosch, and B. U. Keller, “Calcium dysregulation in amyotrophic lateral sclerosis,” Cell Calcium, vol. 47, no. 2, pp. 165–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Foran and D. Trotti, “Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis,” Antioxidants and Redox Signaling, vol. 11, no. 7, pp. 1587–1602, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. P. van Damme, M. Dewil, W. Robberecht, and L. van den Bosch, “Excitotoxicity and amyotrophic lateral sclerosis,” Neurodegenerative Diseases, vol. 2, no. 3-4, pp. 147–159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. van den Bosch, P. van Damme, E. Bogaert, and W. Robberecht, “The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1762, no. 11-12, pp. 1068–1082, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. L. H. Barbeito, M. Pehar, P. Cassina et al., “A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis,” Brain Research Reviews, vol. 47, no. 1–3, pp. 263–274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Garbuzova-Davis, S. Saporta, E. Haller et al., “Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS,” PLoS ONE, vol. 2, no. 11, article e1205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Nicaise, D. Mitrecic, P. Demetter et al., “Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat,” Brain Research, vol. 1301, pp. 152–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. E. Nwaobi, E. Lin, S. R. Peramsetty et al., “DNA methylation functions as a critical regulator of Kir4. 1 expression during CNS development,” Glia, vol. 62, no. 3, pp. 411–427, 2014. View at Google Scholar
  14. H. Kawamat, S. K. Ng, N. Diaz et al., “Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis,” The Journal of Neuroscience, vol. 34, no. 6, pp. 2331–2348, 2014. View at Google Scholar
  15. K. Meyer, L. Ferraiuolo, C. J. Miranda et al., “Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 2, pp. 829–832, 2014. View at Google Scholar
  16. S. K. Pirooznia, V. L. Dawson, and T. M. Dawson, “Motor neuron death in ALS: programmed by astrocytes?” Neuron, vol. 81, no. 5, pp. 961–963, 2014. View at Google Scholar
  17. J. Tong, C. Huang, F. Bi et al., “Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats,” The EMBO Journal, vol. 32, no. 13, pp. 1917–1926, 2013. View at Google Scholar
  18. M. Gandelman, H. Peluffo, J. S. Beckman, P. Cassina, and L. Barbeito, “Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: Implications for amyotrophic lateral sclerosis,” Journal of Neuroinflammation, vol. 7, article 33, 2013. View at Google Scholar · View at Scopus
  19. T. Philips and W. Robberecht, “Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease,” The Lancet Neurology, vol. 10, no. 3, pp. 253–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. McCombe and R. D. Henderson, “The role of immune and inflammatory mechanisms in ALS,” Current Molecular Medicine, vol. 11, no. 3, pp. 246–254, 2011. View at Google Scholar · View at Scopus
  21. P. R. Andjus, D. Bataveljić, G. Vanhoutte et al., “In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach,” Anatomical Record, vol. 292, no. 12, pp. 1882–1892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. R. Turner, R. Bowser, L. Bruijn et al., “Mechanisms, models and biomarkers in amyotrophic lateral sclerosis,” Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 14, supplement 1, pp. 19–32, 2013. View at Google Scholar
  23. M. B. A. Oldstone, C. B. Wilson, L. H. Perrin, and F. H. Norris Jr., “Evidence for immune complex formation in patients with amyotrophic lateral sclerosis,” The Lancet, vol. 2, no. 7978, pp. 169–172, 1976. View at Google Scholar · View at Scopus
  24. T. G. Tachovsky, R. P. Lisak, and H. Koprowski, “Circulating immune complexes in multiple sclerosis and other neurological diseases,” The Lancet, vol. 2, no. 7993, pp. 997–999, 1976. View at Google Scholar · View at Scopus
  25. H. Bartfeld, C. Dham, and H. Donnenfeld, “Immunological profile of amyotrophic lateral sclerosis patients and their cell mediated immune responses to viral and CNS antigens,” Clinical and Experimental Immunology, vol. 48, no. 1, pp. 137–146, 1982. View at Google Scholar · View at Scopus
  26. S. Apostolski, J. Nikolić, C. Bugarski-Prokopljević et al., “Serum and CSF immunological findings in ALS,” Acta Neurologica Scandinavica, vol. 83, no. 2, pp. 96–98, 1991. View at Google Scholar
  27. I. A. Saleh, T. Zesiewicz, Y. Xie et al., “Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression,” Journal of Neuroimmunology, vol. 215, no. 1-2, pp. 96–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Provinciali, M. A. Laurenzi, L. Vesprini et al., “Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets,” Acta Neurologica Scandinavica, vol. 78, no. 6, pp. 449–454, 1988. View at Google Scholar · View at Scopus
  29. F. Duarte, S. Binet, L. Lacomblez, P. Bouche, J.-L. Preud'homme, and V. Meininger, “Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis,” Journal of the Neurological Sciences, vol. 104, no. 1, pp. 88–91, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. M. E. Westarp, P. Bartmann, and H. Kornhuber, “Immunoglobulin-G isotype changes in human sporadic amyotrophic lateral sclerosis (ALS),” Neuroscience Letters, vol. 173, no. 1-2, pp. 124–126, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. H. J. Willison, A. M. Chancellor, J. Veitch, P. G. E. Kennedy, and C. P. Warlow, “Immunoglobulin G subclasses are normal in motor neuron disease,” Journal of the Neurological Sciences, vol. 124, no. 1, pp. 115–116, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Zhang, R. Gascon, R. G. Miller et al., “Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS),” Journal of Neuroimmunology, vol. 159, no. 1-2, pp. 215–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. H. Appel, J. I. Engelhardt, J. Garcia, and E. Stefani, “Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 2, pp. 647–651, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. A. H. Pullen, M. Demestre, R. S. Howard, and R. W. Orrell, “Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement,” Acta Neuropathologica, vol. 107, no. 1, pp. 35–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. E. Alexianu, A. H. Mohamed, R. G. Smith, L. V. Colom, and S. H. Appel, “Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis,” Journal of Neurochemistry, vol. 63, no. 6, pp. 2365–2368, 1994. View at Google Scholar · View at Scopus
  36. F. H. Yi, C. Lautrette, C. Vermot-Desroches et al., “In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients,” Journal of Neuroimmunology, vol. 109, no. 2, pp. 211–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Demestre, A. Pullen, R. W. Orrell, and M. Orth, “ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures,” Journal of Neurochemistry, vol. 94, no. 1, pp. 268–275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. O. D. Uchitel, S. H. Appel, F. Crawford, and L. Sczcupak, “Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 19, pp. 7371–7374, 1988. View at Google Scholar · View at Scopus
  39. J. I. Engelhardt, L. Siklos, L. Komuves, R. G. Smith, and S. H. Appel, “Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons,” Synapse, vol. 20, no. 3, pp. 185–199, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. S. A. Fratantoni, G. Weisz, A. M. Pardal et al., “Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker,” Muscle Nerve, vol. 23, no. 4, pp. 543–550, 2000. View at Google Scholar
  41. A. H. Pullen and P. Humphreys, “Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls,” Journal of the Neurological Sciences, vol. 180, no. 1-2, pp. 35–45, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. M. R. Pagani, R. C. Reisin, and O. D. Uchitel, “Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals,” The Journal of Neuroscience, vol. 26, no. 10, pp. 2661–2672, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Llinas, M. Sugimori, B. D. Cherksey et al., “IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11743–11747, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. A. B. Zhainazarov, P. Annunziata, S. Toneatto, E. Cherubini, and A. Nistri, “Serum fractions from amyotrophic lateral sclerosis patients depress voltage-activated Ca2+ currents of rat cerebellar granule cells in culture,” Neuroscience Letters, vol. 172, no. 1-2, pp. 111–114, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. P. R. Andjus, Z. Stevic-Marinkovic, and E. Cherubini, “Immunoglobulins from motoneurone disease patients enhance glutamate release from rat hippocampal neurones in culture,” The Journal of Physiology, vol. 504, no. 1, pp. 103–112, 1997. View at Google Scholar
  46. P. R. Andjus, L. Khiroug, A. Nistri et al., “ALS IgGs suppress Ca2+i rise through P/Q-type calcium channels in central neurones in culture,” Neuroreport, vol. 7, no. 12, pp. 1914–1916, 1996. View at Google Scholar
  47. L. E. Gonzalez, M. L. Kotler, L. G. Vattino et al., “Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels,” Journal of Neurochemistry, vol. 119, no. 4, pp. 826–838, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Li, X. Liu, Z. Li et al., “Effect of ALS IgG on motor neurons in organotypic spinal cord cultures,” Canadian Journal of Neurological Sciences, vol. 35, no. 2, pp. 220–225, 2008. View at Google Scholar · View at Scopus
  49. K. Yamanaka, S. J. Chun, S. Boillee et al., “Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis,” Nature Neuroscience, vol. 11, no. 3, pp. 251–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Boillée, K. Yamanaka, C. S. Lobsiger et al., “Onset and progression in inherited ALS determined by motor neurons and microglia,” Science, vol. 312, no. 5778, pp. 1389–1392, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Stenovec, M. Milošević, V. Petrušić et al., “Amyotrophic lateral sclerosis immunoglobulins G enhance the mobility of Lysotracker-labelled vesicles in cultured rat astrocytes,” Acta Physiologica, vol. 203, no. 4, pp. 457–471, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Milošević, M. Stenovec, M. Kreft et al., “Immunoglobulins G from patients with sporadic amyotrophic lateral sclerosis affects cytosolic Ca2+ homeostasis in cultured rat astrocytes,” Cell Calcium, vol. 54, no. 1, pp. 17–25, 2013. View at Google Scholar
  53. E. B. Malarkey, Y. Ni, and V. Parpura, “Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes,” Glia, vol. 56, no. 8, pp. 821–835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. B. L. Stiles, “PI-3-K and AKT: onto the mitochondria,” Advanced Drug Delivery Reviews, vol. 61, no. 14, pp. 1276–1282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. I. Engelhardt, J. Soós, I. Obál, L. Vigh, and L. Siklós, “Subcellular localization of IgG from the sera of ALS patients in the nervous system,” Acta Neurologica Scandinavica, vol. 112, no. 2, pp. 126–133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Zhong, R. Deane, Z. Ali et al., “ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration,” Nature Neuroscience, vol. 11, no. 4, pp. 420–422, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Garbuzova-Davis, E. Haller, S. Saporta, I. Kolomey, S. V. Nicosia, and P. R. Sanberg, “Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS,” Brain Research, vol. 1157, no. 1, pp. 126–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Garbuzova-Davis, D. G. Hernandez-Ontiveros, M. C. Rodrigues et al., “Impaired blood-brain/spinal cord barrier in ALS patients,” Brain Research, vol. 1469, pp. 114–128, 2012. View at Google Scholar
  59. B. V. Zlokovic, “The blood-brain barrier in health and chronic neurodegenerative disorders,” Neuron, vol. 57, no. 2, pp. 178–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Nielsen, E. A. Nagelhus, M. Amiry-Moghaddam et al., “Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain,” The Journal of Neuroscience, vol. 17, no. 1, pp. 171–180, 1997. View at Google Scholar
  61. E. A. Newman, D. A. Frambach, and L. L. Odette, “Control of extracellular potassium levels by retinal glial cell K+ siphoning,” Science, vol. 225, no. 4667, pp. 1174–1175, 1984. View at Google Scholar · View at Scopus
  62. E. A. Nagelhus, Y. Horio, A. Inanobe et al., “Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Mülller cells is mediated by a coenrichment of Kir4. 1 and AQP4 in specific membrane domains,” Glia, vol. 26, no. 1, pp. 47–54, 1999. View at Google Scholar
  63. N. N. Haj-Yasein, G. F. Vindedal, M. Eilert-Olsen et al., “Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 43, pp. 17815–17820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Bataveljić, N. Djogo, L. Župunski et al., “Live monitoring of brain damage in the rat model of amyotrophic lateral sclerosis,” General Physiology and Biophysics, vol. 28, pp. 212–218, 2009. View at Google Scholar · View at Scopus
  65. D. Bataveljić, L. Nikolić, M. Milosević et al., “Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model,” Glia, vol. 60, no. 12, pp. 1991–2003, 2012. View at Google Scholar
  66. C. Nicaise, M. S. Soyfoo, M. Authelet et al., “Aquaporin-4 overexpression in rat ALS model,” Anatomical Record, vol. 292, no. 2, pp. 207–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Kaiser, I. Maletzki, S. Hülsmann et al., “Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis,” Journal of Neurochemistry, vol. 99, no. 3, pp. 900–912, 2006. View at Publisher · View at Google Scholar · View at Scopus